Search
for
Sort by
Research 871–900 of 1000+
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Alopecia areata – hyperactivity of the hypothalamic–pituitary–adrenal axis is a myth?
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata
- Familial patterns of alopecia areata: A systematic review and meta-analysis
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Efficacy of a mixed preparation containing piperine, capsaicin and curcumin in the treatment of alopecia areata
- Bidirectional association between alopecia areata and migraine: A nationwide population-based cohort study
- Minoxidil-induced hypertrichosis in a child with alopecia areata
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Drug-induced alopecia areata: A systematic review
- The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- Targeted photochemotherapy in alopecia areata
- HAIR TONIC FORMULATION OF CLOVE LEAVES (SYZYGIUM AROMATICUM) ETHANOL EXTRACT AND THE EFFECTIVENESS ON RABBIT HAIR GROWTH
- Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study
- Knowledge, beliefs and perceptions among alopecia areata patients: A cross-sectional study in Faisalabad
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia
- Complete responses and SALT zero scores in alopecia areata: not the same
- Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata
- Adult patients with alopecia areata report a significantly better medication adherence compared to those with atopic dermatitis: Results from a large cross-sectional cohort study
- Efficacy of therapy with 311nm narrow-band UVB 311nm in the treatment of patients with alopecia areata associated with atopic dermatitis
- Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
- Out-of-Pocket Costs in Alopecia Areata: A Cross-Sectional Study in German-speaking Countries
- Association of Baldness with Coronary Artery Disease and Its Severity
- Azathiopine for the Treatment of Extensive Forms of Alopecia Areata: A Systematic Review
- Noninvasive Assessment of Donor Area in Patients with Androgenetic Alopecia undergoing Hair Transplantation by Digital Imaging Technique